Study Of Vicor Technologies' PD2i(R) Nonlinear Algorithm As Measure Of Diabetic Autonomic Neuropathy Published In Clinical Neurophysiology

Links shared publicly online about this topic.

  • 214
    total visits

Study Of Vicor Technologies' PD2i(R) Nonlinear Algorithm As Measure Of Diabetic Autonomic Neuropathy Published In Clinical Neurophysiology

medicalnewstoday.com

David H. Fater, CEO of Vicor Technologies, Inc. (OTCBB: VCRT), today announced that a manuscript detailing a study of the ability of its PD2i Analyzer™ to detect the presence of autonomic ne

View full resource at medicalnewstoday.com

Tags: Diabetes

  • Share

Most Recently Shared on June 16, 2011 at 5:41 pm By:

HeartsHealth Heart Health

MedicalNewsToday: Study Of Vicor Technologies' PD2i(R) Nonlinear Algorithm As Measure Of: http://bit.ly/kslxYM Full http://bit.ly/lpO0tg

12 months ago...

Also Shared By:

MNT Diabetes News MNT Diabetes News

MNT Cardiovascular MNT Cardiovascular

Advertisement